Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1965 3
1966 8
1967 4
1968 5
1969 6
1970 1
1971 4
1972 6
1973 8
1974 10
1975 13
1976 9
1977 13
1978 12
1979 22
1980 14
1981 12
1982 24
1983 27
1984 14
1985 21
1986 15
1987 21
1988 25
1989 32
1990 31
1991 31
1992 34
1993 42
1994 42
1995 51
1996 49
1997 27
1998 35
1999 45
2000 29
2001 20
2002 21
2003 21
2004 18
2005 20
2006 15
2007 14
2008 16
2009 12
2010 13
2011 22
2012 15
2013 20
2014 16
2015 14
2016 24
2017 23
2018 36
2019 27
2020 29
2021 30
2022 29
2023 24
2024 21
2025 42
2026 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,230 results

Results by year

Filters applied: . Clear all
Page 1
Difference in vasoconstrictors: oxymetazoline vs. brimonidine.
Okwundu N, Cline A, Feldman SR. Okwundu N, et al. J Dermatolog Treat. 2021 Mar;32(2):137-143. doi: 10.1080/09546634.2019.1639606. Epub 2019 Aug 12. J Dermatolog Treat. 2021. PMID: 31294643 Free article. Review.
OBJECTIVE: Topical oxymetazoline and brimonidine are the only medications approved for treating persistent facial erythema of rosacea. This review aims to investigate the efficacy, safety, pharmacodynamics, and pharmacokinetic properties of oxymetazoline and brimoni …
OBJECTIVE: Topical oxymetazoline and brimonidine are the only medications approved for treating persistent facial erythema of rosacea …
Management of Severe Botulinum-Induced Eyelid Ptosis With Pretarsal Botulinum Toxin and Oxymetazoline Hydrochloride 0.1.
Bernardini FP, Skippen B, Croasdell B, Cerón Bohórquez JM, Murray G, Sayed K, Walker L, Hartstein ME; Complications in Medical Aesthetics Collaborative (CMAC) Study Group. Bernardini FP, et al. Aesthet Surg J. 2023 Aug 17;43(9):955-961. doi: 10.1093/asj/sjad070. Aesthet Surg J. 2023. PMID: 36943792
OBJECTIVES: The aim of this study was to describe a case series of patients treated effectively with topical oxymetazoline HCl 0.1% and pretarsal BoNT-A injections in the setting of botox-induced ptosis. ...CONCLUSIONS: This is the first documented case series of patients …
OBJECTIVES: The aim of this study was to describe a case series of patients treated effectively with topical oxymetazoline HCl 0.1% a …
Oxymetazoline for Ptosis.
Bradley EA, Bradley DJ. Bradley EA, et al. JAMA Ophthalmol. 2020 Nov 1;138(11):1176-1177. doi: 10.1001/jamaophthalmol.2020.3833. JAMA Ophthalmol. 2020. PMID: 33001145 No abstract available.
Role of Topical Oxymetazoline for Management of Erythematotelangiectatic Rosacea.
Hoover RM, Erramouspe J. Hoover RM, et al. Ann Pharmacother. 2018 Mar;52(3):263-267. doi: 10.1177/1060028017740139. Epub 2017 Nov 2. Ann Pharmacother. 2018. PMID: 29094614 Review.
DATA SYNTHESIS: Data support the efficacy of oxymetazoline for persistent facial redness. Little study beyond clinical trials cited in the drug approval process has been conducted. ...CONCLUSION: The topical alpha-agonist, oxymetazoline, is safe and effective for re …
DATA SYNTHESIS: Data support the efficacy of oxymetazoline for persistent facial redness. Little study beyond clinical trials cited i …
Efficacy and safety of oxymetazoline for the treatment of rosacea: A meta-analysis.
Liu F, Zhou Q, Wang H, Fu H, Li Y, Tao M, Luo H, Cao Y. Liu F, et al. J Cosmet Dermatol. 2023 Sep;22(9):2408-2419. doi: 10.1111/jocd.15747. Epub 2023 May 2. J Cosmet Dermatol. 2023. PMID: 37128814 Review.
BACKGROUND: Since there is currently no conclusion on the efficacy and adverse effects of oxymetazoline, this meta-analysis attempts to explore its efficacy and adverse events, so as to provide guidance for clinical medication. ...CONCLUSION: Oxymetazoline is effect …
BACKGROUND: Since there is currently no conclusion on the efficacy and adverse effects of oxymetazoline, this meta-analysis attempts …
Intranasal corticosteroid and oxymetazoline for chronic rhinitis: a systematic review.
Neighbors CL, Salvador CF, Zhu B, Camacho M, Tsai P. Neighbors CL, et al. J Laryngol Otol. 2022 Jan;136(1):8-16. doi: 10.1017/S0022215121003364. Epub 2021 Oct 27. J Laryngol Otol. 2022. PMID: 34702392
The study found superior improvement of nasal congestion from onset of treatment to completion in intranasal corticosteroid spray and oxymetazoline hydrochloride groups compared with control groups. Intranasal corticosteroid spray and oxymetazoline hydrochloride use …
The study found superior improvement of nasal congestion from onset of treatment to completion in intranasal corticosteroid spray and oxy …
Oxymetazoline.
Covington TR, Pau AK. Covington TR, et al. Am Pharm. 1985 May;NS25(5):21-6. doi: 10.1016/s0160-3450(16)32692-7. Am Pharm. 1985. PMID: 4003266 No abstract available.
Oxymetazoline hydrochloride cream for facial erythema associated with rosacea.
Patel NU, Shukla S, Zaki J, Feldman SR. Patel NU, et al. Expert Rev Clin Pharmacol. 2017 Oct;10(10):1049-1054. doi: 10.1080/17512433.2017.1370370. Epub 2017 Aug 24. Expert Rev Clin Pharmacol. 2017. PMID: 28837365 Review.
A primarily alpha-1a agonist, oxymetazoline hydrochloride (HCl) is thought to diminish erythema through vasoconstriction. ...As further evidence becomes available, the real-world clinical potential of topical oxymetazoline cream will become clearer....
A primarily alpha-1a agonist, oxymetazoline hydrochloride (HCl) is thought to diminish erythema through vasoconstriction. ...As furth …
Efficacy of Widely Used Topical Drugs for Rosacea: A Systematic Review and Meta-Analysis.
Gao X, Xiang W. Gao X, et al. Actas Dermosifiliogr. 2025 Sep;116(8):863-875. doi: 10.1016/j.ad.2024.12.026. Epub 2025 Apr 15. Actas Dermosifiliogr. 2025. PMID: 40246142 Free article. English, Spanish.
According to 21 randomized controlled trials included, a total of 6 topical drugs including minocycline, ivermectin, azelaic acid, metronidazole, brimonidine and oxymetazoline were reported. These drugs are well-tolerated and safe. Ivermectin is more effective than azelaic …
According to 21 randomized controlled trials included, a total of 6 topical drugs including minocycline, ivermectin, azelaic acid, metronida …
Oxymetazoline-Induced Asthma.
Shah S, Patel K, Gambhir HS. Shah S, et al. Am J Ther. 2018 Nov/Dec;25(6):e681-e682. doi: 10.1097/MJT.0000000000000628. Am J Ther. 2018. PMID: 28901959 No abstract available.
1,230 results